TP53 and hepatocellular carcinoma: Xiao et al. [112] coupled anti-PD-1 treatment with CXCR4-targeted p53 mRNA NPs, which successfully promoted complete reprogramming of the immunological TME's molecular and cellular components, thereby reversing immunosuppression in HCC.